EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event

Another election year hearing on drug prices yielded more of the same discussions on price hikes and FDA's approval process.

EpiPen

Highlighted by attacks on a lack of transparency in drug pricing and a series of guilt trips and drive-by shots at FDA, the House Oversight Committee hearing on the EpiPen price spike proved to be a virtual bootleg of a hearing held by the same committee in February.

Members of the committee – who are gearing up for reelection in November – took turns grilling Mylan Pharmaceuticals...

More from Pricing Debate

More from Market Access